Fingerprint
Dive into the research topics of 'Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2
Sha Chen, Qian Wang, Diane Bakker, Xin Hu, Liping Zhang, Ingeborg van der Made, Anna M. Tebbens, Csenger Kovacshazi, Zoltan Giricz, Gabor B. Brenner, Peter Ferdinandy, Gert Schaart, Anne Gemmink, Matthijs K. C. Hesselink, Mathilde R. Rivaud, Michael P. Pieper, Markus W. Hollmann, Nina C. Weber, Jean-Luc Balligand, Esther E. Creemers
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review